STK32A Polyclonal antibody

STK32A Polyclonal Antibody for WB, ELISA
Cat No. 16223-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse, rat

应用

WB, ELISA

serine/threonine kinase 32A, STK32A, YANK1

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inHeLa cells, MCF-7 cells

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

发表文章中的应用

WBSee 1 publications below

产品信息

16223-1-AP targets STK32A in WB, ELISA applications and shows reactivity with human, mouse, rat samples.

经测试应用 WB, ELISA Application Description
文献引用应用WB
经测试反应性 human, mouse, rat
文献引用反应性human
免疫原 STK32A fusion protein Ag9276 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 serine/threonine kinase 32A
别名 serine/threonine kinase 32A, STK32A, YANK1
计算分子量396aa,46 kDa; 166aa,20 kDa
观测分子量 46 kDa
GenBank蛋白编号BC021666
基因名称 STK32A
Gene ID (NCBI) 202374
RRIDAB_2196485
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDQ8WU08
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

STK32A(Serine/threonine-protein kinase 32A) is also named as YANK1 and belongs to Ser/Thr protein kinase family. It can affect cell metabolism by protein serine/threonine kinase phosphorylation. The gene encoding STK32A maps to human chromosome 5 and this gene is associated with Cockayne syndrome through the ERCC8 gene and familial adenomatous polyposis through the adenomatous polyposis coli (APC) tumor suppressor gene.

实验方案

Product Specific Protocols
WB protocol for STK32A antibody 16223-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanWB

Free Radic Biol Med

NOX1 triggers ferroptosis and ferritinophagy, contributes to Parkinson's disease

Authors - Huiqing Wang
Loading...